BACKGROUND AND OBJECTIVES: Exercise capacity is impaired at a younger age in CKD patients than in the general population. This study examined the reliability of the Duke Activity Status Index (DASI) questionnaire as a measure of exercise capacity in medically stable adults with stage 3-4 CKD (estimated GFR [eGFR], 15-59 ml/min per 1.73 m(2)). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Peak oxygen uptake (VO(2)peak), estimated from DASI responses and cardiopulmonary exercise test measurements, was obtained at baseline and 6 months in a derivation sample (n=23) and once in a validation sample (n=20). Bland-Altman analysis and linear mixed models were used to estimate bias, concordance correlation coefficients, and intraclass correlation coefficients as the proportion of the variance due to participant (intertest reliability) and method (test-retest reliability). RESULTS: The two samples were homogeneous with respect to age (mean 60 ± 14 years), eGFR (35.5 ± 15 ml/min per 1.73 m(2)), male sex (53%), and diabetes (56%). Mean measured VO(2)peak was 16.5 ± 4 ml/kg per min. The DASI questionnaire overestimated VO(2)peak by 4.3 ml/kg per min. Intertest reliability was 53% when eGFR was ≥35 ml/min per 1.73 m(2) (median) and 60% when eGFR was <35 ml/min per 1.73 m(2) (P<0.01). Test-retest reliability was 81% when eGFR was <35 ml/min per 1.73 m(2) and 71% when eGFR was ≥35 ml/min per 1.73 m(2) (P<0.01). CONCLUSIONS: The DASI questionnaire may be a reliable measure of exercise capacity in CKD patients, especially when eGFR is <35 ml/min per 1.73 m(2). Larger prospective studies are needed to determine its prognostic value.
BACKGROUND AND OBJECTIVES: Exercise capacity is impaired at a younger age in CKDpatients than in the general population. This study examined the reliability of the Duke Activity Status Index (DASI) questionnaire as a measure of exercise capacity in medically stable adults with stage 3-4 CKD (estimated GFR [eGFR], 15-59 ml/min per 1.73 m(2)). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Peak oxygen uptake (VO(2)peak), estimated from DASI responses and cardiopulmonary exercise test measurements, was obtained at baseline and 6 months in a derivation sample (n=23) and once in a validation sample (n=20). Bland-Altman analysis and linear mixed models were used to estimate bias, concordance correlation coefficients, and intraclass correlation coefficients as the proportion of the variance due to participant (intertest reliability) and method (test-retest reliability). RESULTS: The two samples were homogeneous with respect to age (mean 60 ± 14 years), eGFR (35.5 ± 15 ml/min per 1.73 m(2)), male sex (53%), and diabetes (56%). Mean measured VO(2)peak was 16.5 ± 4 ml/kg per min. The DASI questionnaire overestimated VO(2)peak by 4.3 ml/kg per min. Intertest reliability was 53% when eGFR was ≥35 ml/min per 1.73 m(2) (median) and 60% when eGFR was <35 ml/min per 1.73 m(2) (P<0.01). Test-retest reliability was 81% when eGFR was <35 ml/min per 1.73 m(2) and 71% when eGFR was ≥35 ml/min per 1.73 m(2) (P<0.01). CONCLUSIONS: The DASI questionnaire may be a reliable measure of exercise capacity in CKDpatients, especially when eGFR is <35 ml/min per 1.73 m(2). Larger prospective studies are needed to determine its prognostic value.
Authors: Makena Pook; Hiba Elhaj; Charbel El Kefraoui; Saba Balvardi; Nicolo Pecorelli; Lawrence Lee; Liane S Feldman; Julio F Fiore Journal: Surg Endosc Date: 2022-02-25 Impact factor: 4.584
Authors: Amy L Clarke; Francesco Zaccardi; Douglas W Gould; Katherine L Hull; Alice C Smith; James O Burton; Thomas Yates Journal: Clin Kidney J Date: 2018-08-28
Authors: W H Wilson Tang; Eric J Topol; Yiying Fan; Yuping Wu; Leslie Cho; Cindy Stevenson; Stephen G Ellis; Stanley L Hazen Journal: J Am Heart Assoc Date: 2014-10-20 Impact factor: 5.501
Authors: Thomas J Wilkinson; Emma L Watson; Douglas W Gould; Soteris Xenophontos; Amy L Clarke; Barbara P Vogt; João L Viana; Alice C Smith Journal: Clin Kidney J Date: 2018-08-13
Authors: Mariana A Coutinho-Myrrha; Rosângela C Dias; Aline A Fernandes; Christiano G Araújo; Mark A Hlatky; Danielle G Pereira; Raquel R Britto Journal: Arq Bras Cardiol Date: 2014-02-17 Impact factor: 2.000
Authors: Emer M Brady; Andrew P Hall; Emma Baldry; Sudesna Chatterjee; Lois J Daniels; Charlotte Edwardson; Kamlesh Khunti; Mubarak I Patel; Joseph J Henson; Alex Rowlands; Alice C Smith; Thomas Yates; Melanie J Davies Journal: BMJ Open Date: 2019-11-11 Impact factor: 2.692
Authors: A C Nixon; T J Wilkinson; H M L Young; M W Taal; N Pendleton; S Mitra; M E Brady; A P Dhaygude; A C Smith Journal: BMC Nephrol Date: 2020-09-23 Impact factor: 2.388